{"id":"W1968622004","doi":"10.3109/10428194.2010.496506","title":"Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?","year":2010,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Ribavirin; IMP dehydrogenase; Cancer; Medicine; Leukemia; Myeloid leukemia; EIF4E; Cancer research; Immunology; Biology; Virus; Hepatitis C virus; Internal medicine; Translation (biology); Transplantation; Mycophenolic acid; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006018875,0.0020323,0.002676182,0.0003757628,0.0006208697,0.0005140417,0.001545091,0.003696938,0.0001005914],"category_scores_gemma":[0.0001048784,0.0017229,0.0009083407,0.0005631238,0.001210162,0.00006020182,0.001291085,0.0008104788,0.00009166455],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001703732,"about_ca_system_score_gemma":0.008324704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008700863,"about_ca_topic_score_gemma":0.00006912162,"domain_scores_codex":[0.9925215,0.0004664758,0.001274553,0.003089015,0.0008602404,0.001788265],"domain_scores_gemma":[0.9956002,0.00009895362,0.000618552,0.002067183,0.0002598898,0.001355283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002317204,0.0001252178,0.00003002718,0.001420269,0.0008164533,0.000196056,0.0000635748,5.122241e-7,0.05631591,0.0002200448,0.001842462,0.9387378],"study_design_scores_gemma":[0.004743515,0.0006360615,0.0001161719,0.0008454552,0.0006892461,0.002100341,0.00003880859,0.00004335436,0.03619254,0.0001554669,0.9523066,0.002132418],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2420578,0.7536455,0.00001807571,0.00004156074,0.0003870807,0.001165964,0.0003435407,0.0001124893,0.002228001],"genre_scores_gemma":[0.005427323,0.9837599,0.0003572144,0.001308879,0.001324471,0.0006472146,0.002148651,0.0004468619,0.004579523],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9504642,"threshold_uncertainty_score":0.9992419,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0170753322536928,"score_gpt":0.3112245452087337,"score_spread":0.2941492129550409,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}